Enquiry Now
Loading...
| A02848 | Pages: NA | Aug 2021 | 4132 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Oxymetholone Powder Market
Request Now !Oxymetholone is a chemical compound used to treat muscle wasting diseases such as AIDS, by allowing the muscle growth even in deprived diets. Oxymethalone powder, brand name Andral, is a pharmaceutical material used to increase body mass and treat different types of anemia such as aplastic anemia, myelofibrosis, or hypoplastic anemia caused due to chemotherapy.
The factors that drive the oxymetholone powder market include rise in incidence of anemia and osteoporosis globally, increase in demand for innovative oral drugs, growth in biologics market, technological advancements, and development of new products such as synthetic male hormone. However, stringent government regulatory requirements for the approval of this drug and associated side effects when taken in large doses restrict the market growth. Furthermore, the introduction of these drugs for treating various disorders such as HIV, mainly in developing countries, and growth in awareness among different healthcare institutions provide numerous opportunities for market expansion.
The global oxymetholone powder market is segmented on the basis of application, distribution network, and region. On the basis of application, it is bifurcated into dietary supplement and disease treatment. Dietary supplement is further bifurcated into patient and personal care. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and specialty pharmacies. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include Heroids Pharmaceutical Co., Ltd, S, Hongkong WinstonChem Technology Co., Ltd., Belco Pharma, Euphoria Healthcare Pvt. Ltd., Zhuhai Wumei Technology Co., Ltd., Syntex Pharmaceuticals, Astra Zeneca, Carbone Scientific Co., Ltd., Kinbester Co., Ltd., Clarlab Co., Ltd., and LGM Pharma.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 OXYMETHOLONE POWDER MARKET, BY APPLICATION
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. DIETARY SUPPLEMENT
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.3.1. Patient care market and forecast
4.2.3.2. Personal care market size and forecast
4.3. DISEASE TREATMENT
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 OXYMETHOLONE POWDER MARKET, BY DISTRIBUTION CHANNEL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITAL PHARMACIES
5.2.1. Market size and forecast
5.3. RETAIL PHARMACIES
5.3.1. Market size and forecast
5.4. SPECIALTY PHARMACIES
5.4.1. Market size and forecast
CHAPTER 6 OXYMETHOLONE POWDER MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America oxymetholone powder market by application
6.2.5. North America oxymetholone powder market by distribution channel
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe oxymetholone powder market by application
6.3.5. Europe oxymetholone powder market by distribution channel
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific oxymetholone powder market by application
6.4.5. Asia-Pacific oxymetholone powder market by distribution channel
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA oxymetholone powder market by application
6.5.5. LAMEA oxymetholone powder market by distribution channel
CHAPTER 7 COMPANY PROFILES
7.1. HEROIDS PHARMACEUTICAL CO., LTD
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. S, HONGKONG WINSTONCHEM TECHNOLOGY CO., LTD
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. BELCO PHARMA
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. LGM PHARMA
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ZHUHAI WUMEI TECHNOLOGY CO., LTD.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. SYNTEX PHARMACEUTICALS
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ASTRA ZENECA
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. CARBONE SCIENTIFIC CO., LTD
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. KINBESTER CO., LTD.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. CLARLAB CO., LTD.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
